The average weight loss on Wegovy is 15% of body weight (approximately 35 pounds) after 68 weeks of treatment with the 2.4mg maintenance dose, according to clinical trial data published in the New England Journal of Medicine. This once-weekly injection, containing the active ingredient semaglutide, works by mimicking a natural hormone called GLP-1 that signals the brain you’re full after eating.
Wegovy works by reducing appetite and helping people feel full for longer after meals—it does not increase metabolism but primarily reduces energy intake. The medication is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related medical problem such as high blood pressure, high cholesterol, or type 2 diabetes. As of 2026, Wegovy is available in both injectable and oral pill forms with comparable efficacy.
TL;DR
- Clinical trials show average 15% body weight loss after 68 weeks on Wegovy’s 2.4mg maintenance dose when combined with a reduced calorie diet and increased physical activity.
- Individual results vary from 5-25%, with 83% of patients losing at least 5% of their starting weight and 48% losing 15% or more.
- Most weight loss occurs within the first 12-18 months, with a plateau expected around months 9-12.
- Physician monitoring is recommended for patients achieving greater than 10% weight loss.
Clinical Trial Weight Loss Data
The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program provides the most comprehensive data on average weight loss with Wegovy. The STEP 1 trial enrolled 1,961 adults with obesity or overweight who did not have diabetes and evaluated them over 68 weeks.
STEP 1 Trial Results (2.4mg vs Placebo)
In clinical trials, participants using Wegovy combined with a reduced-calorie diet and increased physical activity achieved remarkable weight loss results compared to the placebo group:
| Time Point | Wegovy 2.4mg | Placebo | % Patients ≥10% Loss |
| 20 weeks | 10% | 2.4% | 66% |
| 68 weeks | 15-17% | 2.5% | 83% |
| Starting weight | 232 lb | 231 lb | N/A |
The change in body weight from baseline to week 68 was -15.3 kg (approximately 33 lb) in the semaglutide group compared with -2.6 kg in the placebo group. Adults without diabetes lost an average of 14.9% to 15.8% of their body weight.
Percentile Breakdown
According to published research, in clinical studies 76% to 86% of users achieve 5% or more weight loss, and roughly one-third maintain a loss of 20% or more over two years:
| Weight Loss Category | % Patients Achieving |
| ≥5% loss | 83% |
| ≥10% loss | 66% |
| ≥15% loss | 48% |
| ≥20% loss | 25% |
Weight loss is generally more modest for those with type 2 diabetes, averaging about 9.6% in clinical trials compared to nearly 15% in those without the condition.
Wegovy Weight Loss Timeline
Understanding the weight loss timeline helps set realistic expectations. Wegovy’s dose is increased slowly over about 16-17 weeks to allow your body to adjust and reduce side effects. The initial dose is 0.25 mg, which is gradually increased to the maximum dose of 2.4 mg, typically reached by week 17 of treatment.
Week-by-Week Expectations Chart
| Week | Dose | Average Loss | Cumulative % |
| Week 4 | 0.5mg | 2-4 lb | 2% |
| Week 12 | 1.0mg | 8-12 lb | 5-6% |
| Week 20 | 1.7mg | 15-20 lb | 10% |
| Week 68 | 2.4mg | 35 lb avg | 15-17% |
- Month 1-3: Rapid phase (water + glycogen loss). Many patients notice appetite changes and reduced food cravings within the first 1-3 weeks.
- Month 4-9: Steady fat loss (peak efficacy). Weight loss results are gradual and most significant after reaching the maintenance dose.
- Month 10+: Plateau/maintenance. Most weight loss occurs within the first year to 18 months, with a plateau effect likely afterward.
Why Not Losing Weight on Wegovy
If you’re taking Wegovy but not seeing expected results, several factors may be at play. Wegovy is most effective when combined with lifestyle changes such as a healthy diet and regular physical activity. Remember, Wegovy does not increase metabolism—it primarily helps reduce energy intake by making patients feel less hungry.
Top 5 Common Plateaus
Patients who adopt healthy habits typically see faster and more significant weight loss when using Wegovy. If side effects are severe or persistent, clinicians may slow down the dose increases to help manage them.
| Issue Priority | Fix Protocol |
| 1. Dose too low | Reach 2.4mg maintenance dose |
| 2. Calorie creep | Track calories with reduced-calorie diet |
| 3. Alcohol consumption | Minimize or eliminate alcohol |
| 4. No resistance training | Add 3x weekly resistance exercises |
| 5. Sleep <7 hours | Prioritize 7-9 hours of sleep |
5 Ways to Maximize Wegovy Results
Long-term success with Wegovy comes from staying consistent and building habits that can be maintained. Users report needing to pair Wegovy with a high-protein, low-carbohydrate diet to maximize results. Combining Wegovy with a reduced-calorie diet and regular physical activity enhances weight loss results.
Evidence-Based Weight Loss Boosters
| Strategy # | Intervention | Expected Boost |
| 1 | High protein intake (160g daily) | +4% loss |
| 2 | Intermittent fasting | +3% loss |
| 3 | Resistance training 4x/week | +3% loss |
| 4 | Carb cycling (low/high days) | +2% loss |
| 5 | Stay hydrated | +1% loss |
Eating smaller meals and avoiding very fatty or heavy meals can help manage Wegovy’s side effects while maximizing results. Combined protocol may yield additional loss beyond standard 15%.
Keeping Weight Off After Wegovy
According to long-term studies, weight loss from Wegovy can be sustained for up to 4 years with continued use. The STEP 5 trial showed mean weight loss of 15.2% maintained at 104 weeks. However, stopping the medication often leads to weight regain, making lifestyle changes essential for long-term success.
4-Year Maintenance Data
| Strategy | Regain Prevention Rate |
| Protein intake 1.6g/kg | 85% success |
| Resistance training 4x/week | 78% success |
| Body recomposition phase | 92% success |
| Gradual medication taper | 65% success |
Why Gaining Weight on Wegovy
Some patients may experience weight regain while on Wegovy due to specific triggers. Understanding these reversal risk factors can help you stay on track toward your goal weight.
Reversal Risk Factors
| Rebound Trigger | Weight Gain Rate | Prevention |
| Weekend binge eating | 2 lb/week | Log all meals |
| Alcohol consumption | 3 lb/month | Minimize intake |
| Early dose reduction | 5 lb/month | Maintain 6+ months on 2.4mg |
Muscle preservation through regular physical activity prevents rebound metabolism drop. Patients are encouraged to work closely with their healthcare providers to monitor progress and adjust their treatment plan as needed.
